The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support
During the COVID-19 pandemic, the use of non-invasive respiratory support (NIRS) became crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral aerosolization, non-invasive respiratory support has gained attention as a way to alleviate ICU overcrowding and re...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/10/3486 |
_version_ | 1797599647871533056 |
---|---|
author | Yorschua Jalil Martina Ferioli Martin Dres |
author_facet | Yorschua Jalil Martina Ferioli Martin Dres |
author_sort | Yorschua Jalil |
collection | DOAJ |
description | During the COVID-19 pandemic, the use of non-invasive respiratory support (NIRS) became crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral aerosolization, non-invasive respiratory support has gained attention as a way to alleviate ICU overcrowding and reduce the risks associated with intubation. The COVID-19 pandemic has led to an unprecedented increased demand for research, resulting in numerous publications on observational studies, clinical trials, reviews, and meta-analyses in the past three years. This comprehensive narrative overview describes the physiological rationale, pre-COVID-19 evidence, and results of observational studies and randomized control trials regarding the use of high-flow nasal oxygen, non-invasive mechanical ventilation, and continuous positive airway pressure in adult patients with COVID-19 and associated acute hypoxemic respiratory failure. The review also highlights the significance of guidelines and recommendations provided by international societies and the need for further well-designed research to determine the optimal use of NIRS in treating this population. |
first_indexed | 2024-03-11T03:37:12Z |
format | Article |
id | doaj.art-2596bc8b761a475f8efc1eb9de3f26db |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-11T03:37:12Z |
publishDate | 2023-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-2596bc8b761a475f8efc1eb9de3f26db2023-11-18T01:53:50ZengMDPI AGJournal of Clinical Medicine2077-03832023-05-011210348610.3390/jcm12103486The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory SupportYorschua Jalil0Martina Ferioli1Martin Dres2INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, 75006 Paris, FranceINSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, 75006 Paris, FranceINSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, 75006 Paris, FranceDuring the COVID-19 pandemic, the use of non-invasive respiratory support (NIRS) became crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral aerosolization, non-invasive respiratory support has gained attention as a way to alleviate ICU overcrowding and reduce the risks associated with intubation. The COVID-19 pandemic has led to an unprecedented increased demand for research, resulting in numerous publications on observational studies, clinical trials, reviews, and meta-analyses in the past three years. This comprehensive narrative overview describes the physiological rationale, pre-COVID-19 evidence, and results of observational studies and randomized control trials regarding the use of high-flow nasal oxygen, non-invasive mechanical ventilation, and continuous positive airway pressure in adult patients with COVID-19 and associated acute hypoxemic respiratory failure. The review also highlights the significance of guidelines and recommendations provided by international societies and the need for further well-designed research to determine the optimal use of NIRS in treating this population.https://www.mdpi.com/2077-0383/12/10/3486COVID-19coronaviruscritical carenon-invasive ventilationCPAPhigh-flow nasal cannula |
spellingShingle | Yorschua Jalil Martina Ferioli Martin Dres The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support Journal of Clinical Medicine COVID-19 coronavirus critical care non-invasive ventilation CPAP high-flow nasal cannula |
title | The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support |
title_full | The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support |
title_fullStr | The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support |
title_full_unstemmed | The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support |
title_short | The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support |
title_sort | covid 19 driving force how it shaped the evidence of non invasive respiratory support |
topic | COVID-19 coronavirus critical care non-invasive ventilation CPAP high-flow nasal cannula |
url | https://www.mdpi.com/2077-0383/12/10/3486 |
work_keys_str_mv | AT yorschuajalil thecovid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport AT martinaferioli thecovid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport AT martindres thecovid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport AT yorschuajalil covid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport AT martinaferioli covid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport AT martindres covid19drivingforcehowitshapedtheevidenceofnoninvasiverespiratorysupport |